AzurRx is a New York-based clinical-stage biopharmaceutical company that researches and develops non-systemic therapies for the treatment of gastrointestinal diseases.
Business Model:
Revenue: $1M
Employees: 11-50
Address: 777 Yamato Road
City: Boca Raton
State: FL
Zip: 33431
Country: US
AzurRx is a New York-based clinical-stage biopharmaceutical company that researches and develops non-systemic therapies for the treatment of gastrointestinal diseases.
Contact Phone:
+15615897020
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
9/23/2021
Ticker Symbol:
FWBI
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2020 | Post-IPO Equity | 1 | $6.9M |
Alexander Capital Alexander Capital Alexander Capital Alexander Capital |
7/2022 | Post-IPO Equity | - | 7/2021 | Post-IPO Equity | $3M | 7/2020 | Post-IPO Debt | $6.9M | 1/2020 | Private Placement | $6.9M | 11/2022 | Post-IPO Equity | $2.5M | 10/2022 | Post-IPO Equity | $6M | 7/2020 | Post-IPO Equity | $15.2M | 6/2017 | Post-IPO Equity | $5M | 2/2019 | Post-IPO Debt | $2M | 7/2021 | Post-IPO Equity | $5.8M | 4/2016 | Seed Round | $635k | 3/2019 | Post-IPO Equity | $2M | 4/2014 | Pre Seed Round | $385k | 2/2022 | Post-IPO Equity | $9M | 7/2022 | Post-IPO Equity | - |
---|
Announced Date | Name | Price |
---|---|---|
9/2021 | First Wave Bio |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|